A Lancet study has highlighted lasting vision improvements in four patients with damaged corneas using reprogrammed stem-cell ...

At the center of this fight is how the FDA regulates a possible "functional cure" for Type 1 diabetes and determines who gets ...

Eledon Pharmaceuticals reports positive Phase 1b data for tegoprubart in kidney transplants. Learn why ELDN stock could ...

The grafts did not form tumours — a known risk of growing iPS cells — and did not show clear signs of being attacked by the ...

After giving birth to Henry from her mother's donated womb, Kirsty Bryant began showing signs of organ rejection before she ...

A groundbreaking advancement in regenerative medicine has emerged as the world’s first vision-restoring stem cell treatment ...

New research on flies suggests that mifepristone may extend lifespan by enhancing cells' ability to clear out damaged ...

Patients who underwent a heart transplant are at an increased risk of developing melanoma when compared with the general population.

Despite reports this fall that the two payers had reopened merger talks, Cigna plans to use excess cash to buy back its ...

Even if only for a few minutes, focus on your breathing. Not only will it help easy your anxieties, but research proves it ...

Abbott has delivered new, longer-term data from a clinical study of its dissolving stent for severe peripheral artery disease ...